Skip to content

ABT

Abbott Laboratories

NYSE · USHealthcareMedical - Devices
$101.72+1.03%

Price as of Jul 20, 2026

ABT capital

Abbott Laboratories capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
Net debt / equity
Debt / assets
Debt / EBITDA
Net debt / EBITDA

Liquidity & coverage

Current ratio
Quick ratio
Cash ratio
Interest coverage
12.45x
EBITDA / interest
15.61x
Working capital

Cash & dividend

FCF / debt
Cash flow / debt
Dividend per share
$2.48
Dividend yield
2.4%
Dividend growth 1y
+7.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.